Apalutamide Recruiting Phase 2 Trials for Low Risk Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03088124Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer